A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants
Clinical trial NCT06181006 · COMPLETED
Trial details
- NCT number
- NCT06181006
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-14
- Primary completion
- 2020-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.